Research and Markets (http://www.researchandmarkets.com/research/fvgj86/global)
has announced the addition of the "Global
Metabolomics Market 2012-2016" report to their offering.
TechNavio's analysts forecast the Global Metabolomics market to grow at
a CAGR of 14.95 percent over the period 2012-2016. One of the key
factors contributing to this market growth is the significant
advancements in R&D activities. The Global Metabolomics market has also
been witnessing the emergence of coordination of standards in
metabolomics. However, the low adoption of metabolomics technology,
especially among large pharmaceutical companies could pose a challenge
to the small vendors and therefore the growth of this market.
The key vendors dminating this market space are Agilent Technologies
Inc., Bio-Rad Laboratories Inc., Bruker Corp., Human Metabolome
Technologies Inc., and Metabolon Inc.
Commenting on the report, an analyst from TechNavio's Healthcare team
said: ''Recently, the Global Metabolomics market has been witnessing a
significant increase in the number of product launches. For instance,
Applied Biosystems inc. launched new TaqMan genotyping assays in 2009.
Bio-Rad Laboratories introduced Bio-Plex Pro cell signaling assays in
July 2012. Moreover, Bio-Rad introduced Bio-Plex assays for immunology
and cancer biomarker research in March 2012. Bruker announced new
quantitative proteomics capabilities with Skyline software in September
2012. GenoLogics Life Sciences Software Inc. announced the availability
of the GenoLogics Rapid Scripting Application Programming Interface
(API) for scientific programmers and bioinformaticians in February
According to the report, most of the reputable vendors in the Global
Metabolomics market are investing significantly in RandD to develop
advanced technologies. Moreover, researchers from the University of
Washington created disk-shaped patches to inspect the option of
generating new tissues with the help of oxygen and nutrient supplies
necessary for living cells. Furthermore, scientists at the University of
Bristol in the UK developed new scaffolds that can be used to grow such
tissues as skin, nerves, and cartilage. These significant developments
and initiatives in R&D are expected to drive the growth of the Global
Metabolomics market during the period 2012-2016.
For more information visit http://www.researchandmarkets.com/research/fvgj86/global
[ Back To NFVZone's Homepage ]